Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001953452 | SCV002242762 | pathogenic | not provided | 2022-11-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ala1520Profs*30) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is present in population databases (rs768092887, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with EYS-related conditions (PMID: 26161267). ClinVar contains an entry for this variant (Variation ID: 1456826). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003471176 | SCV004193513 | pathogenic | Retinitis pigmentosa 25 | 2023-03-19 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888943 | SCV004707504 | pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Fulgent Genetics, |
RCV003471176 | SCV005670606 | likely pathogenic | Retinitis pigmentosa 25 | 2024-01-05 | criteria provided, single submitter | clinical testing |